FNY Investment Advisers LLC Makes New $613,000 Investment in Doximity, Inc. (NASDAQ:DOCS)

FNY Investment Advisers LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,500 shares of the company’s stock, valued at approximately $613,000.

Several other large investors also recently modified their holdings of DOCS. FMR LLC grew its position in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after buying an additional 1,598,602 shares in the last quarter. Lord Abbett & CO. LLC acquired a new position in shares of Doximity during the third quarter valued at about $29,453,000. Los Angeles Capital Management LLC increased its holdings in Doximity by 6,242.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 650,874 shares of the company’s stock worth $28,359,000 after purchasing an additional 640,612 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new position in Doximity during the 3rd quarter valued at $24,691,000. Finally, Geode Capital Management LLC boosted its holdings in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after purchasing an additional 472,565 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Stock Performance

Shares of NASDAQ DOCS opened at $49.50 on Tuesday. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75. The company’s fifty day moving average price is $53.23 and its 200 day moving average price is $41.93. The company has a market capitalization of $9.24 billion, a PE ratio of 56.90, a price-to-earnings-growth ratio of 4.13 and a beta of 1.40.

Analyst Ratings Changes

DOCS has been the subject of a number of research analyst reports. Wells Fargo & Company raised their price objective on shares of Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a report on Monday. Morgan Stanley raised shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Raymond James reaffirmed an “outperform” rating and issued a $65.00 price target (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Stephens assumed coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 target price on the stock. Finally, KeyCorp lowered their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Thirteen equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $53.12.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.